Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
Net Income (Common)
Fulgent Genetics Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Net Income (Common)
-$167.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Net Income (Common)
$691.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
34%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Income (Common)
$843m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Net Income (Common)
$8.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
Cigna Corp
NYSE:CI
|
Net Income (Common)
$5.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Income (Common)
$433.1m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
See Also
What is Fulgent Genetics Inc's Net Income (Common)?
Net Income (Common)
-167.8m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Net Income (Common) amounts to -167.8m USD.
What is Fulgent Genetics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-97%